Prostate leiomyosarcoma: A rare tumor
1 Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.
1 Department of Radiotherapy, Casablanca Cancer Center, Cheikh Khalifa International Hospital, Casablanca, Morocco.
2 Department of Pathological Anatomy, Cheikh Khalifa International Hospital, Casablanca, Morocco.
3 Department of medical Oncology, Casablanca Cancer Center, Cheikh Khalifa International Hospital, Casablanca, Morocco.
Case Study
GSC Advanced Research and Reviews, 2021, 09(02), 103–107.
Article DOI: 10.30574/gscarr.2021.9.2.0257
Publication history:
Received on 02 October 2021; revised on 15 November 2021; accepted on 17 November 2021
Abstract:
Leiomyosarcoma is a rare neoplasm with a poor survival rate. Between June 2018 to January 2019 we treated a rare case of Prostate Leiomyosarcoma initially metastatic to the lung and the liver with multiple pelviclymph nodes. Five cycles of chemotherapy and palliative radiotherapy have been delivered with a mean follow up of 1 year .Chestabdominal-pelvic CT scan with MRI and bone scan are necessarily to assess clinical staging. The objective of this study is to review our experience in the management of Prostate Leiomyosarcoma at the Casablanca Cancer Center of Mohammed VI University of Health Sciences with a literature review of this rare neoplasm.
Keywords:
Prostate leiomyosarcoma; Multimodal treatment; Genitourinary sarcoma; Onco-Urology; Case Report
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
